Akums Drugs gets patent certificate from Government of India

13 Sep 2024 Evaluate

Akums Drugs & Pharmaceuticals has received Patent Certificate (enclosed) from the Patent Office, Government of India. The company has received Patent Certificate on September 12, 2024, for its invention titled ‘Room Stable Hydroxyurea Oral Suspension’ valid for a term of 20 years in accordance with the provisions of the Patents Act, 1970.

The Patent ‘Room Stable Hydroxyurea Oral Suspension’ is a breakthrough formulation aimed at managing Sickle Cell Disease (SCD). This development reinforces company’s role as an innovator in pharmaceutical solutions, offering a significant advance in addressing the storage and accessibility challenges associated with Hydroxyurea solution.

Akums Drugs & Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.


Akums Drugs & Pharmaceuticals Share Price

609.95 29.00 (4.99%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.